Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

NCT03816839 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to prematurely stop the study, not linked to any safety concern.

Conditions

Interventions

Sponsor

Sanofi